Genetic drugs stories

Jul 9, 2026

Dr. Reddy's Delays Generic Ozempic Launch Due to Ingredient Quality Issue

Indian drugmaker Dr. Reddy's Laboratories announced it is delaying commercial production of its generic semaglutide (Ozempic) after discovering an unspecified issue with the active pharmaceutical ingredient in some batches. Shares fell as much as 6.5%.

Jul 9, 20262 sources

00

Apr 30, 2026

Supreme Court Hears Arguments on 'Skinny Labeling' Generic Drug Case

The Supreme Court heard oral arguments on a case involving 'skinny labeling' practices that have significant implications for generic drug availability and access, with justices appearing to signal the practice may survive legal challenge.

Apr 30, 20262 sources

00

Related timelines

Genetic drugs stories

Dr. Reddy's Delays Generic Ozempic Launch Due to Ingredient Quality Issue

Supreme Court Hears Arguments on 'Skinny Labeling' Generic Drug Case

Related timelines

US Congress

Venture capital funding

Iran War

Strait of Hormuz blockage

Trump administration